Histiocytoid carcinoma of the male breast

Annals of Diagnostic Pathology

Volumn 15, Issue 3, 2011, Pages 190-193

  Hutchinson, C Blake ^a   Geradts, Joseph ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Histiocytoid carcinoma; Male breast cancer

Indexed keywords

ANDROGEN RECEPTOR; CD68 ANTIGEN; CYTOKERATIN; CYTOKERATIN 7; CYTOKERATIN AE1; CYTOKERATIN AE3; EPITHELIAL MEMBRANE ANTIGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; UVOMORULIN; VIMENTIN;

AGED; ARTICLE; BREAST CARCINOMA; CANCER INFILTRATION; CANCER SURGERY; CASE REPORT; FEMALE; HISTIOCYTOID BREAST CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAMMOGRAPHY; MASTECTOMY; MEDICAL HISTORY; NEEDLE BIOPSY; PRIORITY JOURNAL;

AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS, MALE; CARCINOMA; HISTIOCYTES; HUMANS; MALE; MASTECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 79955920706     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2010.02.008     Document Type: Article

References (12)

1. Hood CI, Font RL, Zimmerman LE. Metastatic mammary carcinoma in the eyelid with histiocytoid appearance. Cancer 1973;31:793-800.
2. Kitamura H, Kitamura H, Shimizu S, Matsukawa H, Arita E. Histiocytoid breast carcinoma: a case report with immunohistochemical and ultrastructural studies. Breast Cancer 1996;3:57-63.
3. Gupta D, Croitoru C, Ayala A, Sahin A, Middleton L. E-cadherin immunohistochemical analysis of histiocytoid carcinoma of the breast. Ann Diagn Pathol 2002;6:141-7. (Pubitemid 34700850)
4. Eusebi V, Foschini MP, Bussolati G, Rosen PP. Myoblastoid (histiocytoid) carcinoma of the breast. A type of apocrine carcinoma. Am J Surg Pathol 1995;19:553-62.
5. Bruce DM, Heys SD, Payne S, Miller ID, Eremin O. Male breast cancer: clinico-pathological features, immunocytochemical characteristics and prognosis. Eur J Surg Oncol 1996;22:42-6. (Pubitemid 26121691)
6. Willsher PC, Leach IH, Ellis IO, et al. Male breast cancer: pathological and immunohistochemical features. Anticancer Res 1997;17:2335-8. (Pubitemid 27320993)
7. Koc M, Oztas S, Erem MT, Ciftcioglu MA, Onuk MD. Invasive lobular carcinoma of the male breast: a case report. Jpn J Clin Oncol 2001;31:444-6. (Pubitemid 33039753)
8. Wang-Rodriguez J, Cross K, Gallagher S, et al. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases. Mod Pathol 2002;15:853-61. (Pubitemid 34919778)
9. Ge Y, Sneige N, Eltorky MA, et al. Immunohistochemical characterization of subtypes of male breast carcinoma. Breast Cancer Res 2009;11:R28 [epub ahead of print].
10. Shimizu S, Kitamura H, Ito T, Nakamura T, Fujisawa J, Matsukawa H. Histiocytoid breast carcinoma: histological, immunohistochemical, ultrastructural, cytological, and clinicopathologic studies. Pathol Int 1998;48:549-56. (Pubitemid 28341093)
11. Domagala W, Wozniak L, Lasota J, Weber K, Osborn M. Vimentin is preferentially expressed in high-grade ductal and medullary, but not lobular breast carcinomas. Am J Pathol 1990;137:1059-64.
12. Eisenberg BL, Bagnall JW, Harding CT. Histiocytoid carcinoma: a variant of breast cancer. J Surg Oncol 1986;31:271-4. (Pubitemid 16104033)